How many analysts have analysed NOVACYT (ALNOV.PA)?
The number of analysts covering NOVACYT (ALNOV.PA) is 7.
NOVACYT (ALNOV.PA) Forecast, Price Target & Analyst Ratings
EPA:ALNOV • FR0010397232
Current stock price
0.385 EUR
+0 (+0.39%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVACYT (ALNOV.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €0.39 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
37.14%
ALNOV.PA was analyzed by 7 analysts. The buy percentage consensus is at 37. So analysts seem to be rather negative about ALNOV.PA.
In the previous month the buy percentage consensus was at a similar level.
ALNOV.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 21.04M -77.28% | 10.621M -49.52% | 19.63M 84.82% | |
| EBITDA YoY % growth | -6.19M -167.69% | -4.477M 27.67% | N/A 582.58% | |
| EBIT YoY % growth | -14.108M -1,217.91% | -14.12M -0.09% | -14.849M -5.16% | |
| Operating Margin | -67.05% | -132.94% | -75.64% | |
| EPS YoY % growth | N/A -84.25% | N/A -42.50% | N/A 8.21% |
All data in GBP
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in GBP
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A